MindMed readying Phase III trials for LSD therapy to treat anxiety

MindMed readying Phase III trials for LSD therapy to treat anxiety

MindMed Inc. said Tuesday it’s on track to launch Phase 3 clinical trials with up to 440 people starting later this year for its treatment of generalized anxiety disorder (GAD) through use of lysergide D-tartrate (LSD) in a clinical setting. 

Leave a Reply

Your email address will not be published. Required fields are marked *

Search this website